FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Pfizer | Merck

Merck ramping up Durham vax campus, plans new lab

Tools

While Merck has been cutting down on its workforce following its mega-merger with Schering-Plough, the Big Pharma company has been steadily ramping up its vaccine operations in Durham, NC.

Payroll at its main vaccine operation is expected to swell from 275 today to some 400 by the end of the year. And this August, Merck will break ground on a 40,000-square-foot testing lab that is slated to open in 2012 with 50 to 60 workers. Work on the campus was launched back in 2004, and Merck is expecting to gain approvals to start selling the vaccines it makes there later this summer.

The region bet big on Merck when it first floated the idea of building a vaccine complex in the area. Merck stands to gain $45 million in hiring incentives if it hits its projected workforce levels. Pfizer, meanwhile, recently announced that it would lay off 50 workers in Durham as it absorbs Wyeth.

- here's the story from the News & Observer
-
read more about Pfizer

Related Articles:
Merck joins coalition backing cutting-edge vaccine plant
Pfizer spreads vaccine R&D in post-merger shakeup


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:
Be the first to comment
More stories about Pfizer   Merck  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.